Aziyo Biologics enters co-marketing agreement with SurGenTec for minimally invasive bone graft delivery: 3 insights

Biologics

Aziyo Biologics agreed to provide its viable bone matrix product ViBone to medical device company SurGenTec for use with the GraftGun universal graft delivery system.

Here are three things to know:

1. ViBone pre-filled cartridges will be marketed through the SurGenTec distribution network.

2. SurGenTec's patented GraftGun system was launched in 2017 to improve intraoperative bone graft material delivery.

3. The combination offering of ViBone and GraftGun pre-filled cartridges is intended to significantly reduce time spent in the operating room.

More articles on biologics:

Cerapedics closes $22M financing round: 3 takeaways

17 major players in the global spine biologics market

Dr. Chad Lavender performs ACL repair with bone marrow: 3 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers